TRV GP IV, LLC
SEC CIK 1688325 · EDGAR
BoughtSold
Most active insiders at TNGX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | TRV GP IV, LLC | 10% | — | $8.86M |
| 2 | Crystal Adam | Pres, R, D | — | $6.33M |
| 3 | Weber Barbara | Dir, Executive COB | — | $374.4K |
| 4 | Beckman Daniella | CFO | — | $126.6K |
| 5 | Ketchum John B | Dir | — | — |
| 6 | Peters Malte | Pres, CEO, Dir | — | — |
| 7 | Rothenberg Mace | Dir | — | — |
| 8 | Gall Matthew | CFO | — | — |
| 9 | Lee Sung | Dir | — | — |
| 10 | Calhoun Lesley Ann | Dir | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-27 | 2025-10-23 | TNGX | Tango Therapeutics, Inc. | TRV GP IV, LLC | 10% | S - Sale | $10.15 | -477.4K | 13.39M | -3% | -$4.85M | |
| 2025-09-29 | 2025-09-25 | TNGX | Tango Therapeutics, Inc. | TRV GP IV, LLC | 10% | S - Sale | $8.02 | -500.0K | 13.86M | -3% | -$4.01M | |
| 2025-09-17 | 2025-09-16 | TNGX | Tango Therapeutics, Inc. | TRV GP IV, LLC | 10% | S - Sale | $7.04 | -363.5K | 14.36M | -2% | -$2.56M | |
| M | 2025-09-09 | 2025-09-05+ | TNGX | Tango Therapeutics, Inc. | TRV GP IV, LLC | 10% | S - Sale | $7.00 | -729.4K | 14.81M | -5% | -$5.11M |
| 2024-09-17 | 2024-09-13 | TNGX | Tango Therapeutics, Inc. | TRV GP IV, LLC | 10% | S - Sale | $10.53 | -67.4K | 16.86M | -0.4% | -$709.7K | |
| 2024-09-09 | 2024-09-05 | TNGX | Tango Therapeutics, Inc. | TRV GP IV, LLC | 10% | S - Sale | $11.56 | -75.0K | 16.93M | -0.4% | -$867.0K | |
| 2024-07-30 | 2024-07-26 | TNGX | Tango Therapeutics, Inc. | TRV GP IV, LLC | 10% | S - Sale | $9.84 | -50.0K | 17.72M | -0.3% | -$492.0K | |
| M | 2023-02-09 | 2023-02-07+ | DNTH | Dianthus Therapeutics, Inc. /DE/ | TRV GP IV, LLC | 10% | S - Sale | $0.8259 | -3.70M | 3.06M | -55% | -$3.06M |
Purchase Sale Sale after option exercise All abbreviations